| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213372 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands |
| 09/13/2007 | US20070213369 Novel non-psychotropic cannabinoids |
| 09/13/2007 | US20070213346 Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213326 Substituted indole compounds and their use as 5-ht6 receptor modulators |
| 09/13/2007 | US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | CA2645110A1 Pharmaceutical composition for external use |
| 09/13/2007 | CA2645070A1 Pharmaceutical composition for external use |
| 09/12/2007 | EP1831207A1 Aminopyrimidine compounds and methods of use |
| 09/12/2007 | EP1831206A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 09/12/2007 | EP1831195A1 5-ht7 receptor antagonists |
| 09/12/2007 | EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 09/12/2007 | EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 09/12/2007 | EP1831168A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases. |
| 09/12/2007 | EP1737840B1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | CN101035877A Electroluminescent materials and devices |
| 09/12/2007 | CN101035769A Pyrimidine urea derivatives as kinase inhibitors |
| 09/12/2007 | CN101035768A Compounds and compositions useful as cathepsin S inhibitors |
| 09/12/2007 | CN101033224A Novel pyrimidines small molecular compound, its preparation method and use |
| 09/12/2007 | CN100336809C Peptide deformylase inhibitors |
| 09/11/2007 | US7268232 Androgen receptor modulators and method of treating disease using the same |
| 09/11/2007 | US7268159 Indolecarboxylic acid derivatives as plasminogen activator inhibitor inhibitors; anticoagulant, antiischemic, and anticarcinogenic agents; noninsulin-dependent diabetes, polycystic ovarian syndrome, cardiovascular disorders, atherosclerosis, alzheimer*s disease, chronic obstructive pulmonary disease |
| 09/11/2007 | US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 09/11/2007 | US7268149 Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/11/2007 | CA2176935C Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/07/2007 | WO2007100851A1 Therapeutic compounds |
| 09/07/2007 | WO2007100739A1 Ccr5 antagonists useful for treating hiv |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007098961A1 4, 5, 6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/07/2007 | WO2007098826A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/07/2007 | WO2007070816A3 Thiophene derivatives as factor xia inhibitors |
| 09/07/2007 | WO2007009963A1 Substituted amides, their preparation and their use as pharmaceuticals |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/07/2007 | CA2644068A1 Therapeutic compounds |
| 09/07/2007 | CA2643323A1 Ccr5 antagonists useful for treating hiv |
| 09/07/2007 | CA2642813A1 Inhibitors of histone deacetylase |
| 09/07/2007 | CA2637530A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 09/06/2007 | US20070208176 Biphenyl derivatives |
| 09/06/2007 | US20070208059 Therapeutic Agents |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208045 Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof |
| 09/06/2007 | US20070208037 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208034 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 09/06/2007 | US20070208018 Quinazoline Derivatives |
| 09/06/2007 | US20070208015 5-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase Modulators |
| 09/06/2007 | US20070208012 Modulation of Pathogenicity |
| 09/06/2007 | US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments |
| 09/06/2007 | US20070207331 Azo compounds and coating compositions containing the azo compounds |
| 09/05/2007 | EP1829869A1 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/05/2007 | EP1829865A2 Chemical compounds |
| 09/05/2007 | EP1828183A1 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 09/05/2007 | EP1828175A2 Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
| 09/05/2007 | EP1828174A1 Azabicyclic muscarinic receptor antagonists |
| 09/05/2007 | EP1828173A1 Enentiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors |
| 09/05/2007 | EP1828167A2 Acrylamide derivatives as antibiotic agents |
| 09/05/2007 | EP1828147A1 Quinoxalines as b-raf inhibitors |
| 09/05/2007 | EP1828146A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 09/05/2007 | EP1828127A2 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 09/05/2007 | EP1828124A1 Biaromatic compounds that modulate ppar type receptors, process for preparing them and use thereof in cosmetic or pharmaceutical compositions |
| 09/05/2007 | EP1828123A1 Indolinones and their use as antiproliferative agents |
| 09/05/2007 | EP1828116A1 Pyrrolidine compounds |
| 09/05/2007 | EP1730116B1 4-carbox pyrazole derivates useful as anti-viral agents |
| 09/05/2007 | EP1618094B1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 09/05/2007 | EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2007 | EP1388540B1 Acrylic esters and use thereof |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | CN101031564A Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 09/05/2007 | CN101031560A Cyclic diaryl ureas suitable as tyrosine kinase inhibitors |
| 09/05/2007 | CN101031558A HIV inhibiting 5-heterocyclyl pyrimidines |
| 09/05/2007 | CN101031550A HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 09/05/2007 | CN101029022A Process for the preparation of 4-phenoxy quinoline derivatives |
| 09/04/2007 | US7265378 Light emitting diodes |
| 09/04/2007 | US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 09/04/2007 | US7265152 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 09/04/2007 | US7265145 Bone disorders; osteoporosis; Paget's disease |
| 09/04/2007 | US7265133 Biphenylylaminocarbonyl-amino- or -oxypiperidine derivatives, e.g., biphenyl-2-ylcarbamic acid 1-[2-({4-[(4-hydroxybenzylamino)methyl]benzoyl}methylamino)ethyl]piperidin-4-yl ester; treating bronchodilation and COPD |
| 09/04/2007 | US7265131 For therapy of disease-states associated with nuclear receptor activity |
| 09/04/2007 | US7265129 Anti-infective biaryl compounds |
| 09/04/2007 | US7265127 Imidazo[1,2-a]pyridine derivatives, especially N-(2-(8-(3-aminocarbonyl-2-pyridyloxy)imidazo[1,2-a]pyrid-3-yl)-1,1-dimethylethyl)-3-(o-isoxazol-3-ylphenoxy)-2-hydroxypropylamine; treating type-2 diabetes and obesity |
| 09/04/2007 | US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 09/04/2007 | US7265121 Chemical compounds |
| 09/04/2007 | US7265120 Pyrazine derivatives and pharmaceutical use thereof |
| 09/04/2007 | US7265116 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |
| 09/04/2007 | US7265114 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 09/04/2007 | US7265112 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |